Literature DB >> 1960302

Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. TAMI-5 Study Group.

D W Muller1, E J Topol, S G Ellis, L H Woodlief, K N Sigmon, D J Kereiakes, B S George, S J Worley, J K Samaha, H Phillips.   

Abstract

This study sought to determine whether clinical variables can be used to identify patients at high risk of recurrent spontaneous myocardial ischemia or hemodynamic compromise during the 1st 4 days after intravenous thrombolysis for acute myocardial infarction. Of 288 patients randomly assigned to a conservative postthrombolysis strategy, 54 (19%) required urgent cardiac catheterization within 24 h; 75 (26%) underwent urgent cardiac catheterization within 4 days of admission. Of the clinical variables examined by multiple logistic regression analysis, only patient age and anterior wall myocardial infarction correlated with the need for urgent cardiac catheterization (p = 0.0016 and p = 0.017, respectively). Compared with recombinant tissue-type plasminogen activator or urokinase monotherapy, combination therapy with these agents was associated with a lower need for acute intervention during the 1st 24 h after admission, but the difference did not reach statistical significance (14% for combination therapy vs. 21% for each agent alone, p = 0.30). Of the 75 patients undergoing urgent coronary angiography, only 39% had an occluded infarct-related artery. Emergency coronary angioplasty was performed in 49% of the patients and coronary artery bypass graft surgery was performed urgently in 3%. Despite these interventions, the need for urgent cardiac catheterization was associated with an in-hospital mortality rate of 7% (vs. 3% in the group not requiring urgent angiography, p = 0.36); mean left ventricular ejection fraction was 50.5 +/- 11% (vs. 54.3 +/- 10.8%, p = 0.12) and regional infarct zone wall motion was -2.68 +/- 1.07 SD/chord (vs. -2.46 +/- 1.19 SD/chord; p = 0.44).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960302     DOI: 10.1016/0735-1097(91)90490-z

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  3 in total

Review 1.  Revascularization Strategies in STEMI with Multivessel Disease: Deciding on Culprit Versus Complete-Ad Hoc or Staged.

Authors:  Shalin Patel; Steven R Bailey
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

2.  Should every patient undergo cardiac catheterization after myocardial infarction?

Authors:  C L Grines
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 3.  Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease.

Authors:  Giuseppe Di Pasquale; Elisa Filippini; Pier Camillo Pavesi; Gianfranco Tortorici; Gianni Casella; Pietro Sangiorgio
Journal:  Intern Emerg Med       Date:  2016-03-07       Impact factor: 3.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.